Allan R Tenorio

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. pmc Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution
    Gregory D Huhn
    Division of Infectious Diseases, The Ruth M, Rothstein CORE Center, 2020 W, Harrison St, Chicago, Illinois, 60612, USA
    AIDS Res Ther 7:44. 2010
  2. ncbi request reprint HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course
    Allan R Tenorio
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Acquir Immune Defic Syndr 34:491-6. 2003
  3. pmc Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115
    Allan R Tenorio
    Department of Medicine, Rush Medical College, Rush University Medical Center, 600 S Paulina Street, Chicago, IL 60612, USA
    AIDS Res Hum Retroviruses 25:135-9. 2009
  4. pmc The effect of aging on T-regulatory cell frequency in HIV infection
    Allan R Tenorio
    Section of Infectious Diseases, Department of Medicine, Rush Medical College, 600 S Paulina Street, Suite 143 AAC, Chicago, Illinois 60612, USA
    Clin Immunol 130:298-303. 2009
  5. doi request reprint The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection
    Allan R Tenorio
    Section of Infectious Disease, Department of Medicine, Rush Medical College, Chicago, IL 60612, USA
    J Acquir Immune Defic Syndr 48:577-80. 2008
  6. pmc Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees
    Allan R Tenorio
    Section of Infectious Diseases, Department of Medicine, Rush Medical College, Chicago, Illinois 60613, USA
    Clin Diagn Lab Immunol 11:758-61. 2004
  7. pmc Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands
    Jeffrey A Martinson
    Department of Immunology and Microbiology, Rush University Medical Center, Cohn Research Building, 1735 West Harrison Street, Chicago, IL 60612, USA
    Cell Immunol 250:75-84. 2007
  8. pmc Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals
    Jeffrey A Martinson
    Department of Immunology Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
    Immunology 120:526-35. 2007
  9. doi request reprint Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface
    Andrew Zloza
    Department of Immunology Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
    Blood 114:3841-53. 2009
  10. pmc Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial
    Benigno Rodriguez
    Division of Infectious Diseases and Center for AIDS Research, Case Western Reserve University University Hospitals of Cleveland, Cleveland, OH Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, CA Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA University of Pittsburgh, Pittsburgh, PA Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD Department of Medicine, Rush University Medical Center, Chicago, IL ViroStatics srl, Sassari, Italy Genetic Immunity, Budapest, Hungary Genetic Immunity, McLean, VA and Social and Scientific Systems, Inc, Silver Spring, MD
    J Acquir Immune Defic Syndr 64:351-9. 2013

Collaborators

Detail Information

Publications12

  1. pmc Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution
    Gregory D Huhn
    Division of Infectious Diseases, The Ruth M, Rothstein CORE Center, 2020 W, Harrison St, Chicago, Illinois, 60612, USA
    AIDS Res Ther 7:44. 2010
    ..abstract:..
  2. ncbi request reprint HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course
    Allan R Tenorio
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Acquir Immune Defic Syndr 34:491-6. 2003
    ..HIV-specific CD4+ T-cell immunity was detected in most subjects with low-level and undetectable viremia and may have a role in controlling viremia in the setting of partial suppression...
  3. pmc Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115
    Allan R Tenorio
    Department of Medicine, Rush Medical College, Rush University Medical Center, 600 S Paulina Street, Chicago, IL 60612, USA
    AIDS Res Hum Retroviruses 25:135-9. 2009
    ..Delaying a treatment switch in patients with partial virologic suppression and stable CD4+ T cells does not have profound effects on immune parameters...
  4. pmc The effect of aging on T-regulatory cell frequency in HIV infection
    Allan R Tenorio
    Section of Infectious Diseases, Department of Medicine, Rush Medical College, 600 S Paulina Street, Suite 143 AAC, Chicago, Illinois 60612, USA
    Clin Immunol 130:298-303. 2009
    ..T-reg percentages are increased in the older HIV(+) population and may play a role in the accelerated disease progression seen in older HIV-infected persons...
  5. doi request reprint The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection
    Allan R Tenorio
    Section of Infectious Disease, Department of Medicine, Rush Medical College, Chicago, IL 60612, USA
    J Acquir Immune Defic Syndr 48:577-80. 2008
    ..Human immunodeficiency virus (HIV) infection is associated with abnormalities in T-regulatory (T-reg) cells, but the effect of HIV on the naive (CD45RO-) and memory (CD45RO) CD25+CD127loCD4+ T-reg cell subsets has not been defined...
  6. pmc Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees
    Allan R Tenorio
    Section of Infectious Diseases, Department of Medicine, Rush Medical College, Chicago, Illinois 60613, USA
    Clin Diagn Lab Immunol 11:758-61. 2004
    ..Vaccinia virus-specific CD8+ CTL responses may be useful in interpreting the response to vaccination, particularly in individuals who are revaccinated and have difficult-to-interpret visual takes...
  7. pmc Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands
    Jeffrey A Martinson
    Department of Immunology and Microbiology, Rush University Medical Center, Cohn Research Building, 1735 West Harrison Street, Chicago, IL 60612, USA
    Cell Immunol 250:75-84. 2007
    ..Understanding pDC and mDC activation and maturation in HIV-1 infection could lead to more rational development of immunotherapeutic strategies to stimulate the adaptive immune response to HIV-1...
  8. pmc Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals
    Jeffrey A Martinson
    Department of Immunology Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
    Immunology 120:526-35. 2007
    ....
  9. doi request reprint Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface
    Andrew Zloza
    Department of Immunology Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
    Blood 114:3841-53. 2009
    ..Collectively, our findings show that CD4(dim)CD8(bright) T cells designate an enriched antiviral subpopulation of CD8+ T cells that should be targeted for therapeutic intervention or evaluation of vaccine efficacy...
  10. pmc Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial
    Benigno Rodriguez
    Division of Infectious Diseases and Center for AIDS Research, Case Western Reserve University University Hospitals of Cleveland, Cleveland, OH Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, CA Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA University of Pittsburgh, Pittsburgh, PA Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD Department of Medicine, Rush University Medical Center, Chicago, IL ViroStatics srl, Sassari, Italy Genetic Immunity, Budapest, Hungary Genetic Immunity, McLean, VA and Social and Scientific Systems, Inc, Silver Spring, MD
    J Acquir Immune Defic Syndr 64:351-9. 2013
    ..DermaVir, a topically administered plasmid DNA-nanomedicine expressing HIV (CladeB) virus-like particles consisting of 15 antigens, induces predominantly central memory T-cell responses...
  11. pmc Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells
    Anvita Kumar
    Rush University Medical Center, Department of Immunology Microbiology, 1735 W Harrison Street, 614 Cohn, Chicago, IL 60612, USA
    J Virol 82:2813-20. 2008
    ..Collectively, these data indicate that beta-catenin signaling is an intrinsic molecular pathway restricting HIV replication in PBMCs...
  12. ncbi request reprint Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA
    Miguel Goicoechea
    Department of Medicine, University of California, San Diego, Antiviral Antiviral Research Center, 92131
    J Infect Dis 194:29-37. 2006
    ..Suboptimal CD4+ T cell recovery during antiretroviral therapy (ART) is a common clinical dilemma...